Ibuprofen Medibond

Ibuprofen, the active ingredient in Ibuprofen Medibond, is a nonsteroidal anti-inflammatory drug (NSAID) presented as an oral tablet for oral use. It relieves mild to moderate pain, reduces fever, and decreases inflammation in adults.

GNH USA supplies Ibuprofen Medibond as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Ibuprofen acts on the cyclooxygenase pathway to reduce prostaglandin synthesis, providing relief across several inflammatory conditions.

- Mild to moderate pain: Provides analgesic relief by lowering prostaglandin‑mediated nociception. - Fever: Lowers elevated body temperature through central thermoregulatory effects. - Osteoarthritis: Improves joint function by decreasing inflammation and pain. - Rheumatoid arthritis: Reduces synovial inflammation and associated discomfort. - Inflammation: Diminishes swelling in various acute inflammatory states.

Adverse reactions may range from mild gastrointestinal discomfort to serious systemic events.

Common Side Effects: - Nausea: Mild stomach upset occurring shortly after ingestion. - Dyspepsia: Indigestion or heartburn sensations. - Headache: Transient cranial discomfort. - Dizziness: Light‑headed feeling, especially on standing. - Rash: Minor skin irritation or erythema. - Diarrhoea: Loose stools without blood.

Serious or Rare Side Effects: - Gastrointestinal ulcer or bleeding: Potential for serious bleeding in the stomach or intestines. - Renal impairment: Reduced kidney function, especially with prolonged use. - Cardiovascular events: Increased risk of heart attack or stroke. - Severe skin reactions: Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Hepatic injury: Elevated liver enzymes or hepatitis. - Anaphylaxis: Rare, life‑threatening allergic reaction.

Before using Ibuprofen Medibond, consider the following safety measures.

- Assess renal function: Use caution in patients with existing kidney disease. - Evaluate gastrointestinal risk: Avoid in individuals with active ulcers or a history of GI bleeding. - Review cardiovascular status: Use the lowest effective dose in patients with heart disease. - Monitor concomitant medications: Check for interactions with anticoagulants, SSRIs, or other NSAIDs. - Pregnancy and lactation: Discuss risks with a healthcare professional before use. - Store at ambient temperature below 25°C: keep in the original pack, protect from moisture.

Ibuprofen can affect the activity of several other medicines; interaction severity varies.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): heightened risk of serious bleeding. - Other NSAIDs: additive gastrointestinal toxicity. - Selective serotonin reuptake inhibitors (SSRIs): increased bleeding tendency.

Moderate Interactions (Monitor Closely): - ACE inhibitors: may reduce renal perfusion, especially in volume‑depleted patients. - Diuretics: combined use can impair kidney function. - Lithium: ibuprofen may raise serum lithium concentrations, requiring monitoring.